US Stock MarketDetailed Quotes

VRDN Viridian Therapeutics

Watchlist
  • 15.610
  • +0.630+4.21%
Close Jul 23 16:00 ET
  • 16.000
  • +0.390+2.50%
Post 17:06 ET
996.27MMarket Cap-3476P/E (TTM)

Viridian Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Viridian Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 8, 2024

Revenue(YoY)

72.00K

-26.53%
EPS(YoY)

-0.79

+50.93%
Analyst Rating

Strong Buy

Jul 23, 2024

Viridian Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 13 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 89.770K--
--2024/Q2-- / 91.690K--
May 8, 20242024/Q172.000K / 79.830K--
--2023/Q472.000K / 154.180K--
--2023/Q372.000K / 101.420K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 89.770K--
--2024/Q2-- / 91.690K--
May 8, 20242024/Q172.000K / 79.830K--
--2023/Q472.000K / 154.180K--
--2023/Q372.000K / 101.420K--

Unlock Free Earnings Estimates

Viridian Therapeutics Earnings Reports

  • Viridian Therapeutics | 10-Q: Quarterly report

    May 8 07:53 ET

  • Viridian Therapeutics | 10-K: Annual report

    Feb 27 16:42 ET

  • Viridian Therapeutics: Q3 2023 Earnings Report

    Nov 13, 2023 16:28 ET

  • Viridian Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 8, 2023 16:31 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 23, 2024

    Strong Buy

    • Buy

      86.67%

    • Hold

      13.33%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg